GB PHARMA ApS: Financial statements 2024
CVR: 36054220
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
GB PHARMA ApS (CVR 36054220) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 42,457 and a net result of DKK -4,949 compared with DKK -30,932 the year before. That is an increase of 90.5% compared with the year before. The profit margin was -11.7%. Equity in the 2024 report amounted to DKK -1,934,455.
- Revenue
- DKK 42,457
- Gross Profit
- DKK 32,644
- Profit/Loss
- DKK -4,949
- Equity
- DKK -1,934,455
- Total Assets
- DKK 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 42 t. | 33 t. | -5 t. | -1.9 mio. | - |
| 2023 | 22 t. | 12 t. | -31 t. | -1.9 mio. | - |
| 2022 | 43 t. | 33 t. | 65 t. | -1.9 mio. | - |
| 2021 | 0 | -10 t. | 3 t. | -2 mio. | - |
| 2020 | 0 | -13 t. | -46 t. | -2 mio. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
GB PHARMA ApS has published its annual report for 2023. Revenue came to DKK 22,285, and the net result was DKK -30,932.
About GB PHARMA ApS
GB PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2014. The company is registered under the industry Detailhandel med kosmetikvarer og toiletartikler. The management consists of Gunnar Kjems. The board consists of Gunnar Kjems (chair). The company is owned by Gunnar Kjems. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -10,000 and a net result of DKK 31,613 compared with DKK -4,949 the year before. Equity in the 2025 report amounted to DKK -1,902,842.